Image Analysis Group

NEWS

Meet IAG’s Musculoskeletal Expert Team at OARSI’24

Join our team to discuss imaging and AI in osteoarthritis drug development.

Meet IAG’s Expert Neuroscience Team at TAU2024

Discuss imaging and AI in Neurodegeneration drug development.

IAG will join Gliobalstoma Drug Development Summit, March 2024

Join IAG in Boston, March 26-28, 2024

IAG will Participate in the 8th Systemic Sclerosis World Congress

Join IAG in Prague, March 14-16, 2024

From Data To Discovery: The Art of DXA Analysis in Research

Perhaps you should consider incorporating DXA!

IAG Strengthens its Leadership Team

IAG names Roughan Sheedy CEO Seasoned Technology Leader to Drive Growth and Innovation at Leading Image Analysis Group. 8 February 2024, London – Image Analysis Group (IAG), a leading provider of image analysis solutions for the biotechnology and pharmaceutical industries, today announced the appointment of Roughan Sheedy as Chief Executive Officer. Dr. Olga Kubassova, IAG’s founder …

IAG will Attend Biotech Week / JPM in San Francisco, USA, 8-11 January 2024

IAG joins the most influential gathering in the life sciences industry.

A Powerful Partnership with AVM Biotechnology: Hope and Progress

Working together with AVM Biotechnology in cancer trials.

VIEWS

Bone Health: New Drugs vs New Tools

The field of bone health is undergoing unprecedented advancements, with novel imaging techniques deployed to take novel platforms through approvals.

Cartilage Repair: Imaging in Treatment Advancements

Critical Role of Imaging is Crucial in Drug Development

Getting approval: the EMA and the FDA

Thinking through drug approval: the FDA and EMA and their requirements.

Imaging Power in Alzheimer’s Disease (AD) Studies

Breakthroughs in AD research and trials rely on accurate imaging and its interpretation.

A Story started by our President, Dr Olga Kubassova

While studying for her PhD at Leeds, UK Olga Kubassova began work on commercialising her research.

BioTech Investing in 2022, Jefferies Conference Reflections

The world saw unprecedented growth in healthcare investing in 2021.

The Promise of Precision Oncology

Artificial Intelligence advancing clinical studies.

Power of Radiomics: Can We Predict Treatment Response to Immunotherapy?

Increase the scientific value of clinical trials and accelerate the drug to market process.

IAG, Image Analysis Group
Leading imaging Clinical Research Organization that combines medical and operational expertise with cutting-edge proprietary A.I. capabilities to power drug development, and to deliver the potential for companion diagnostic tool. IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to III imaging trials across multiple indications. With a pioneering proven innovation strategy, we enhance the value and market potential of novel therapeutic assets, as demonstrated through successful pharmaceutical partnerships.
DYNAMIKA, Image Management Platform
Our team helps to optimise imaging studies by leveraging our in-house radiology expertise in the design and execution of trials, and through our cutting-edge DYNAMIKA platform, which allows for effective imaging data management, supported site workflow and accelerated patient recruitment. DYNAMIKA supports seamless data collection, real-time image Quality Control and central review. DYNAMIKA brings AI / ML into trial process to allow for a fully transparent data management, trial execution control and central review.
Global Client Services: Clinical Trials
At IAG, we strategically use imaging, such as MRI, CT, and PET to accelerate drug development and lower investment risks into R&D. Whether you are entering a phase I-III and need early robust efficacy data or planning an A.I. powered innovation project, our science, operations, and technology teams will work with you to develop the right solution.
Our Publications

Since 2007, many articles were published to cover scientific discoveries, technology break-throughs and special cases. We list here some critically important papers and abstracts.